- Home
- LGVN vs HOOK Comparison
LGVN vs HOOK Comparison
Compare LGVN & HOOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGVN
- HOOK
- Stock Information
- Founded
- LGVN 2014
- HOOK 2011
- Country
- LGVN United States
- HOOK United States
- Employees
- LGVN N/A
- HOOK N/A
- Industry
- LGVN Medicinal Chemicals and Botanical Products
- HOOK Biotechnology: Pharmaceutical Preparations
- Sector
- LGVN Health Care
- HOOK Health Care
- Exchange
- LGVN Nasdaq
- HOOK Nasdaq
- Market Cap
- LGVN 25.2M
- HOOK 24.5M
- IPO Year
- LGVN 2021
- HOOK 2019
- Fundamental
- Price
- LGVN $1.56
- HOOK $1.78
- Analyst Decision
- LGVN Strong Buy
- HOOK Buy
- Analyst Count
- LGVN 3
- HOOK 4
- Target Price
- LGVN $8.67
- HOOK $10.67
- AVG Volume (30 Days)
- LGVN 161.2K
- HOOK 43.6K
- Earning Date
- LGVN 02-28-2025
- HOOK 03-21-2025
- Dividend Yield
- LGVN N/A
- HOOK N/A
- EPS Growth
- LGVN N/A
- HOOK N/A
- EPS
- LGVN N/A
- HOOK N/A
- Revenue
- LGVN $1,852,000.00
- HOOK $49,999,000.00
- Revenue This Year
- LGVN $208.32
- HOOK $148.80
- Revenue Next Year
- LGVN $43.96
- HOOK N/A
- P/E Ratio
- LGVN N/A
- HOOK N/A
- Revenue Growth
- LGVN 141.46
- HOOK 143.30
- 52 Week Low
- LGVN $0.77
- HOOK $1.65
- 52 Week High
- LGVN $6.40
- HOOK $10.50
- Technical
- Relative Strength Index (RSI)
- LGVN 45.58
- HOOK 41.23
- Support Level
- LGVN $1.53
- HOOK $1.77
- Resistance Level
- LGVN $1.71
- HOOK $1.96
- Average True Range (ATR)
- LGVN 0.13
- HOOK 0.12
- MACD
- LGVN 0.02
- HOOK 0.00
- Stochastic Oscillator
- LGVN 38.30
- HOOK 41.40
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.